Cortex | St. Louis Public Radio


This article first appeared in the St. Louis Beacon, June 16, 2010 - Six months after a "wave" of 600 laid-off research scientists began exiting the St. Louis branch of Pfizer, Karen Bailey could find herself the last one out the door in this latest mass shedding of local corporate jobs.

"I've swept the floors and turned out the lights," Bailey joked last week, as she prepares for her own departure next month. She and about a half-dozen of her "already gone" colleagues have remained behind to complete projects at the Chesterfield facility, where about 450 Pfizer researchers remain with the company. The reorganization cut the Pfizer presence in St. Louis by more than half.